Healthcare -
Biotechnology - NASDAQ - US
$ 0.8465
3.31 %
$ 306 M
Market Cap
-1.14
P/E
LXRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities LXRX - Lexicon Pharmaceuticals, Inc.
188 M
LAST VALUE
187.70%
2 YEAR CAGR
143.59%
5 YEAR CAGR
63.60%
10 YEAR CAGR